## CHRW: C.H. Robinson Worldwide, Inc. - XLI: Industrials

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 5.7% in upper entry zone (3.0-6.0%), top 3% cross-sectional ranking. Short-term MRS_5 (3.3%) confirms momentum alignment. Strong momentum (+4.7% 5-day acceleration). Outperforming sector by 4.5%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($157.17)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Is C.H. Robinson Stock Outperforming the Dow?**
- Source: Markets Financial Content | 20251216T070736 | Bullish | Relevance: 100%
- C.H. Robinson Worldwide, Inc. (CHRW) stock has significantly outperformed the Dow Jones Industrial Average, with gains of 18.3% in three months, 41.5% in 52 weeks, and 52.6% year-to-date. This strong performance is supported by robust Q3 2025 adjusted EPS growth and an increased 2026 operating income target. Wall Street analysts maintain a "Moderate Buy" rating for CHRW, indicating continued confidence in its trajectory.

**2. C.H. Robinson Worldwide, Inc. $CHRW Shares Bought by Nilsine Partners LLC**
- Source: MarketBeat | 20251217T112001 | Somewhat-Bullish | Relevance: 100%
- Nilsine Partners LLC significantly increased its stake in C.H. Robinson Worldwide, Inc. by 113.1% in the third quarter, acquiring an additional 6,560 shares. This move brings their total holdings to 12,359 shares, valued at approximately $1.64 million. The sentiment comes amidst recent large insider sales, a raised quarterly dividend, reported Q3 earnings beating estimates, and a "Moderate Buy" consensus from analysts.

**3. Barclays Upgrades C.H. Robinson Worldwide (CHRW)**
- Source: Nasdaq | 20251217T000807 | Somewhat-Bullish | Relevance: 100%
- Barclays has upgraded its outlook for C.H. Robinson Worldwide (CHRW) from Equal-Weight to Overweight. Despite this upgrade, the average one-year price target suggests a 3.72% downside from its current closing price, with institutional ownership showing a slight increase in total shares but varied portfolio allocations among major holders.

**4. Is C.H. Robinson Stock Outperforming the Dow?**
- Source: Barchart.com | 20251216T073037 | Bullish | Relevance: 100%
- C.H. Robinson Worldwide, Inc. (CHRW) stock has significantly outperformed the Dow Jones Industrial Average ($DOWI) over the past three months, 52 weeks, and year-to-date, signaling strong investor confidence despite revenue declines. The company reaffirmed its profitability narrative by raising its 2026 operating income target and trading above analyst price targets, with a "Moderate Buy" rating. This performance also outpaces its rival, Expeditors International of Washington, Inc. (EXPD).

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Stifel | $184 | $155 | +19% |
| 2025-12-16 | Barclays | $200 | $145 | +38% |
| 2025-12-08 | Morgan Stanley | $85 | $77 | +10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Stifel | main | Buy |
| 2025-12-16 | Barclays | up | Overweight |
| 2025-12-08 | Morgan Stanley | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 4 ($1.86M) |
| Sells | 2 ($0.38M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 54.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.0% (-3.0%)
- First Eagle Investme: 8.9% (-0.2%)
- Blackrock Inc.: 8.2% (-8.5%)
- Wellington Managemen: 6.1% (+198.6%)
- State Street Corpora: 5.8% (-7.4%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 3 raises (avg +22%) could attract flows.
- Momentum building: MRS_10 improving +4.7% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.25 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 34%). Analyst sentiment positive (3 raises, avg +22%). Insider buying signal ($1.9M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.5B |
| Beta | 0.91 |
| 52W Range | $84.68 - $165.92 |
| Short Interest | 7.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.25 |
| Forward P/E | 27.5 |
| Current P/E | 33.1 |
| YoY Growth | 20.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 1.1% to 5.7% (+4.7% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 96th percentile. MRS_5 at 3.3% confirms short-term momentum alignment. Outperforming sector by 4.5pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +MTH (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 5.74% (CS: 97) | Strong |
| RSI_14 | 68.4 | Neutral |
| MACD Histogram | -0.09 | Bearish |
| vs SMA20 | 1.048x | Above |
| vs SMA50 | 1.125x | Above |
| vs SMA200 | 1.419x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $165.03
- **Stop Loss:** $157.17 (4.8% risk)
- **Target:** $176.82 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 90
- **Position Value:** $14,852.70
- **Portfolio %:** 14.85%
- **Risk Dollars:** $712.50
- **Risk Per Trade:** 0.71%
- **Modifiers:** L1 95% | L2 75% | Combined 0.71x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-01-28 (Est: $1.13)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.30 | $1.40 | +7.4% |
| 2025Q2 | $1.16 | $1.29 | +11.6% |
| 2025Q1 | $1.05 | $1.17 | +11.4% |
| 2024Q4 | $1.11 | $1.21 | +9.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*